GLANSOPREX

GLANSOPREX LANSOPRAZOLE DELAYED RELEASE CAPSULE USP 30mg

  • Healing and maintenance of duodenal ulcer
  • Treatment of active benign gastric ulcer
  • Risk of reduction of NSAID associated gastric ulcer
  • Treatment of pathological hypersecretory conditions like Zollinger elision syndrome
Category:

COMPOSITION
Each film coated tablet contains:
Bicalutamide USP 50mg
Excipients q.s
Colour: Titanium Dioxide

CLINICAL PHARMACOLOGY
Mechanism of action
Bicalutamide is a non-steroidal androgen receptor inhibitor. It competitively inhibits the action of androgens by binding to cytosol and logen receptors in the target tissue. Prostatic carcinoma is known to be androgen sensitive and responds to treatment that counteracts the effects of androgen and / or removes the source of androgen.

There are no reviews yet.

Be the first to review “GLANSOPREX”